Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Permixon vs Placebo in Symptomatic BPH (PERLES)
NCT02121613Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Apr 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of permixon in benign prostatic hyperplasia (BPH), sponsored by Pierre Fabre Laboratories. Started Apr 2014; status: completed.
02
Drugs
permixon
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02121613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02121613.